Dawn Friedman

Dawn Friedman, MBA, has extensive experience in the pharmaceutical sales industry, specializing in biologics within the immunology field. Currently serving as a Biologic Clinical Account Sales Specialist at UCB since December 2014, Dawn is responsible for the education, promotion, and marketing of Cimzia (Certolizumab pegol) to both Rheumatologists and Gastroenterologists. Previous positions include roles at Bristol-Myers Squibb, where Dawn successfully launched Orencia (abatacept) and contributed to increasing market share and sales for rheumatology treatments. Early career experience includes hospital sales with Cumberland Pharmaceuticals and specialty sales with Knoll Pharmaceuticals, demonstrating a strong background in building relationships with healthcare professionals. Dawn holds a Bachelor of Arts in Marketing from Stockton University and an MBA from Webster University.